/Charles%20River%20Laboratories%20International%20Inc_%20logo-%20by%20IgorGolovniov%20via%20Shutterstock.jpg)
Charles River Laboratories underperformed the broader market over the past year, and Wall Street analysts remain moderately optimistic about the stock’s prospects.
S&P 500 EW Health Care Invesco ETF (RSPH)
27.94 x 200 31.75 x 100
Post-market by (Cboe BZX)
29.85 -0.13 (-0.43%) 03/21/25 [NYSE Arca]
27.94 x 200 31.75 x 100
Post-market 29.85 unch (unch) 20:00 ET
for Fri, Mar 21st, 2025